Literature DB >> 11602783

Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia.

Valeria Ivaniushina1,2, Nadjia Radjef1, Marfa Alexeeva3, Elyanne Gault1, Sergei Semenov3, Mohammed Salhi1, Oleg Kiselev2, Paul Dény1.   

Abstract

Currently, three genotypes of hepatitis delta virus (HDV) are described. The most common, genotype I, has a worldwide distribution; in contrast, genotype II has been found previously only in Japan and Taiwan, while genotype III is found exclusively in South America. Considering the high prevalence of HDV in Northern Siberia (Russia), restriction fragment length polymorphism (RFLP) was used to analyse HDV genotypes from 29 infected patients living in Yakutia. Of these isolates, 11 were characterized by partial nucleotide sequencing and two isolates were completely sequenced. Phylogenetic inference methods included maximum parsimony, maximum likelihood and distance analyses. A restriction pattern consistent with HDV genotype I was found in 14 samples, while the remaining 15 showed a different restriction pattern, inconsistent with any known genotype. Five Yakutian HDV isolates with the type I restriction pattern were sequenced and confirmed to be affiliated with genotype I, although the phylogenetic results indicate that they were heterogeneous and did not cluster together. Sequencing of eight isolates with the new RFLP pattern revealed that these isolates were most closely related to HDV genotype II. In contrast to HDV Yakutian genotype I sequences, all of these type II sequences formed a well-defined clade on phylogenetic trees. Comparison of clinical presentations during hospitalization between patients infected with HDV type I (n=14) and type II (n=15) did not reveal any differences in the severity of infection. These data indicate that the distribution of genotype II is not restricted to Taiwan or Japan, but spreads over Northern Asia, appearing in the native population of Yakutia. Type II Yakutian strains appeared to form a well-defined subclade and could be associated with severe chronic hepatitis in this area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602783     DOI: 10.1099/0022-1317-82-11-2709

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

1.  High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon.

Authors:  Yacouba Foupouapouognigni; Dominique Noah Noah; Michèle Tagni Sartre; Richard Njouom
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

2.  Alpha interferon and ribavirin combination therapy of chronic hepatitis D.

Authors:  Sabahattin Kaymakoglu; Cetin Karaca; Kadir Demir; Sule Poturoglu; Ahmet Danalioglu; Selim Badur; Murvet Bozaci; Fatih Besisik; Yilmaz Cakaloglu; Atilla Okten
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Molecular phylogenetic analysis of Iranian HDV complete genome.

Authors:  Farida Behzadian; Farzaneh Sabahi; Mohsen Karimi; Majid Sadeghizadeh; Nader Maghsoudi; Ramin Sarrami Forooshani; Leila Shahinsaz
Journal:  Virus Genes       Date:  2005-05       Impact factor: 2.332

4.  Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon.

Authors:  S Ramia; M El-Zaatari; A I Sharara; F Ramlawi; B Farhat
Journal:  Epidemiol Infect       Date:  2006-12-19       Impact factor: 2.451

5.  Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.

Authors:  Marie-Bernadette Villiers; Jean-Claude Cortay; Sandra Cortès; Bénédicte Bloquel; Ségolène Brichler; Carine Brakha; Alan Kay; Nisrine Falah; Fabien Zoulim; Christophe Marquette; Patrice N Marche; Paul Dény
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

7.  Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification.

Authors:  Frédéric Le Gal; Samira Dziri; Athenaïs Gerber; Chakib Alloui; Zahia Ben Abdesselam; Dominique Roulot; Ségolène Brichler; Emmanuel Gordien
Journal:  J Clin Microbiol       Date:  2016-11-23       Impact factor: 5.948

8.  RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells.

Authors:  Tzu-Chi Wang; Mei Chao
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 9.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

10.  Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.

Authors:  Hsuan Hui Shih; King-Song Jeng; Wan-Jr Syu; Yi-Hsiang Huang; Chien-Wei Su; Wei-Li Peng; I-Jane Sheen; Jaw-Ching Wu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.